Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-29 @ 3:05 PM
Study NCT ID:
NCT01292460
Status:
COMPLETED
Last Update Posted:
2013-03-13
First Post:
2011-02-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies
Sponsor:
Santen Oy
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-09
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-08
First Submit QC Date:
None
Study First Post Date:
2011-02-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-12
Last Update Post Date:
2013-03-13
Last Update Post Date Type:
ESTIMATED